China National Medicines Corporation Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 24,098.84 million compared to CNY 22,001.19 million a year ago. Revenue was CNY 24,140.18 million compared to CNY 22,006.49 million a year ago.

Net income was CNY 984.58 million compared to CNY 862.25 million a year ago. Basic earnings per share from continuing operations was CNY 1.3049 compared to CNY 1.1428 a year ago. Diluted earnings per share from continuing operations was CNY 1.3049 compared to CNY 1.1428 a year ago.